एलजी इलेक्ट्रॉनिक्स इंडिया ने लिस्टिंग के बाद दर्ज की अपनी सबसे मजबूत तिमाही वृद्धि

राजस्व 15.5% बढ़ा, पीएटी में 27.2% की वृद्धि, एबिटा मार्जिन 106 बीपीएस बढ़कर 12.5% हुआ नई दिल्ली,1 सितंबर: भारत के अग्रणी कंज्यूमर इलेक्ट्रॉनिक्स ब्रांड, एलजी इलेक्ट्रॉनिक्स इंडिया लिमिटेड (एलजीई इंडिया) ने आज वित्त वर्ष 27 की पहली तिमाही के नतीजों की घोषणा की। कंपनी ने अपने पोर्टफोलियो की हर श्रेणी में वृद्धि और सभी श्रेणियों में प्रीमियम उत्पादों की मांग के दम पर लाभप्रदता में स्थायी बढ़त के साथ साल की शुरुआत […]

Continue Reading
A B Cotspin

A B Cotspin India Ltd. Reports Strong Q1 FY27 Performance with 52.89% Revenue Growth and 20.93% PAT Growth YoY

New Delhi [India], August 19: A B Cotspin India Ltd. (NSE: ABCOTS | BSE: 544522), a leading textile manufacturer with over 25 years of industry expertise, has announced its Unaudited Standalone Financial Results for the quarter ended June 30, 2026. The Company delivered strong year-on-year growth during Q1 FY27, led by a significant increase in […]

Continue Reading
Veerhealth

Veerhealth Care Limited Reports Strong Q1 FY27 Performance with 388% YoY Revenue Growth and 412.50% YoY PAT Up

New Delhi [India], August 18: Veerhealth Care Limited (BSE: VEERHEALTH), one of India’s growing listed companies in the Vegan Ayurvedic and Herbal Cosmetics segment, has reported a strong performance for the first quarter of FY2026-27, supported by growth in export sales, new product categories and expanding domestic and international opportunities. Q1 FY27 Financial Highlights The […]

Continue Reading
Chandan Healthcare Delivers Strong Q1 FY27; Total Income at ₹82 Cr, EBITDA Surges 42% YoY to ₹21 Cr, PAT Rises 30% YoY

Chandan Healthcare Delivers Strong Q1 FY27; Total Income at ₹82 Cr, EBITDA Surges 42% YoY to ₹21 Cr, PAT Rises 30% YoY

Lucknow, (Uttar Pradesh) [India], August 18: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading players in Diagnostic sector having Pan India presence, has announced its unaudited Financial Results for Q1 FY27. Consolidated Key Financial Highlights Q1 FY27 Consolidated Key Financial Highlights (YoY) Total Income of ₹ 82.26 Cr, YoY […]

Continue Reading

Patel Retail reports strong Q1FY27 performance; Revenue rises 69.7 Percent YoY to Rs. 309.54 crore

Profit After Tax grows 37.57% YoY to Rs. 9.52 crore, supported by strong business momentum Mumbai (Maharashtra) [India], August 13: Patel Retail Limited, a growing organised retail and food processing company with a strong presence across the Mumbai Metropolitan Region, announced its Q1FY27 financial results following a meeting of its Board of Directors held on […]

Continue Reading

KRN Heat Exchanger Reports Robust Q1 FY27 with Triple-Digit Growth

Jaipur [Rajasthan], May 21: KRN Heat Exchanger and Refrigeration Limited (BSE: 544263 | INE0Q3J01015 | NSE: KRN), one of the prominent manufacturers and exporters of aluminium/copper fins, copper tube heat exchangers, water coils, and condenser and evaporator coils has announced its Unaudited Financial Results for Q1 FY27 Key Financial Highlights  Q1 FY27 Standalone Key Financial […]

Continue Reading

Sumeet Industries Reports Q1 FY27 Total Income of Rs 272.74 Cr, Up 9.17% YoY; Confident of Delivering 30%+ Revenue Growth in FY27

Surat (Gujarat) [India], August 6: Sumeet Industries Limited (NSE Code: SUMEETINDS, BSE Code: 514211), one of the leading integrated polyester manufacturers engaged in the production of Pet Chips, Partially Oriented Yarn (POY), Fully Drawn Yarn (FDY) and Polyester Texturized Yarn, has announced its Unaudited Financial Results for Q1 FY27. Key Consolidated Financial Highlights  Q1 FY27 Total Income: ₹272.74 Cr EBITDA: ₹8.85 Cr EBITDA Margin: 3.24% […]

Continue Reading

Fredun Pharmaceuticals Delivers Stellar Q1 FY27 Performance; Revenue Jumps 90%, EBITDA Surges 93% and Profit Rises 95% YoY

Mumbai (Maharashtra) [India], August 6: Fredun Pharmaceuticals Limited (BSE: FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Q1 FY27 Standalone Financial Highlights Total Income of ₹228.25 Cr, YoY […]

Continue Reading